| 1 |
10069525 | Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans. | 1999 |
1 |
| 2 |
10206483 | Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans. | 1999 Apr |
2 |
| 3 |
9084013 | Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. | 1997 Mar-Apr |
1 |
| 4 |
9188761 | Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans. | 1997 |
2 |
| 5 |
7472937 | Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide. | 1995 Jul |
1 |
| 6 |
1713709 | Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. | 1991 Jun |
1 |
| 7 |
1996640 | Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. | 1991 Feb |
2 |
| 8 |
3902553 | Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. | 1985 Dec |
3 |
| 9 |
3968978 | Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. | 1985 Feb 11 |
1 |
| 10 |
4064569 | Human pancreatic and biliary responses to physiological concentrations of cholecystokinin octapeptide. | 1985 Sep |
1 |